Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wiesner

Showing results (11-20 of 432) with videos related to

Pageof 44
Sort By:
Mayo Clinic Proceedings|June 11, 1998
Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: predicting outcomes with natural history modelsR H Wiesner
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 1, 2015
In a rapidly changing world, can we truly predict the impact of liver graft quality 15 years from now?Russell H Wiesner
Hepatology (Baltimore, Md.)|April 27, 2011
Apply sound scientific methodology to the evaluation of new medical treatmentsRussell H Wiesner
Best Practice & Research. Clinical Gastroenterology|August 9, 2001
Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of diseaseR H Wiesner
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 24, 2004
MELD/PELD and the allocation of deceased donor livers for status 1 recipients with acute fulminant hepatic failure, primary nonfunction, hepatic artery thrombosis, and acute Wilson's diseaseRussell H Wiesner
Hepatology (Baltimore, Md.)|November 26, 2008
Is there disease progression in patients who are hepatitis C virus antibody-positive and hepatitis C virus RNA-seronegative?Russell H Wiesner
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 2013
Moving toward evidence-based liver allocation in patients with primary sclerosing cholangitisRussell H Wiesner
Clinics in Liver Disease|July 15, 2014
Evolving trends in liver transplantation: listing and liver donor allocationRussell H Wiesner
Transplantation|September 12, 1998
A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study GroupR H Wiesner
Transplantation Proceedings|June 24, 1998
Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study GroupR H Wiesner
Pageof 44

Showing results (11-20 of 432) with videos related to

Sort By:
Pageof 44
Mayo Clinic Proceedings|June 11, 1998
Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: predicting outcomes with natural history modelsR H Wiesner
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 1, 2015
In a rapidly changing world, can we truly predict the impact of liver graft quality 15 years from now?Russell H Wiesner
Hepatology (Baltimore, Md.)|April 27, 2011
Apply sound scientific methodology to the evaluation of new medical treatmentsRussell H Wiesner
Best Practice & Research. Clinical Gastroenterology|August 9, 2001
Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of diseaseR H Wiesner
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 24, 2004
MELD/PELD and the allocation of deceased donor livers for status 1 recipients with acute fulminant hepatic failure, primary nonfunction, hepatic artery thrombosis, and acute Wilson's diseaseRussell H Wiesner
Hepatology (Baltimore, Md.)|November 26, 2008
Is there disease progression in patients who are hepatitis C virus antibody-positive and hepatitis C virus RNA-seronegative?Russell H Wiesner
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 2013
Moving toward evidence-based liver allocation in patients with primary sclerosing cholangitisRussell H Wiesner
Clinics in Liver Disease|July 15, 2014
Evolving trends in liver transplantation: listing and liver donor allocationRussell H Wiesner
Transplantation|September 12, 1998
A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study GroupR H Wiesner
Transplantation Proceedings|June 24, 1998
Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study GroupR H Wiesner
Pageof 44